Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1987-12-17
1989-02-28
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540488, A61K 3133, C07D28114
Patent
active
048085804
ABSTRACT:
Compounds of the formula: ##STR1## wherein R.sub.1 is phenyl substituted with 1 to 3 substituents selected from the group consisting of lower alkoxy and halogen; R.sub.2 is hydroxy, lower alkoxy, lower alkanoyloxy, lower cycloalkylcarbonyloxy; ##STR2## or ##STR3## R.sub.3 and R.sub.4 are independently lower alkyl, phenyl lower alkyl or together form a piperidine or pyrrolidine ring; n is 2 to 4; m is 1 to 2; or pharmaceutically acceptable acid addition salts thereof are described. The compounds of formula I have activity as calcium channel blockers and accordingly, are useful as agents for lowering blood pressure, and as agents for treating ischemia.
REFERENCES:
patent: 3562257 (1971-02-01), Kugita et al.
patent: 4438035 (1984-03-01), Gaino et al.
patent: 4490292 (1984-12-01), Maki et al.
patent: 4547495 (1985-10-01), Maiorana et al.
patent: 4566995 (1986-01-01), Simonovitch et al.
patent: 4567175 (1986-01-01), Takeda et al.
patent: 4652561 (1987-03-01), Mohacsi et al.
Kugita et al., Chem. Pharm. Bull. 18 (10) 2028-2037 (1970).
Kugita et al., Chem. Pharm. Bull. 19 595-602 (1971).
Meshi et al., Chem. Pharm. Bull. 19 (8) 1546-1556 (1971).
Sato et al., Arzneim-Forsch. (Drug. Res.) Jahrgant 21 Nr. 9 (1971) 1338-1342.
Inoue et al., Chem. Soc. Perkin Trans. I (1984) 1725-1732.
CA 71(15): 70657j (1969).
CA 77(1): 5554h (1972).
CA 75(9): 63848b (1971).
CA 75(5): 36165v (1971).
CA 74(25): 141721a (1971).
CA 78(19): 119419u (1973).
CA 75(9): 61652j (1971).
CA 97(18): 150634b (1982).
CA 77(1): 105c (1972).
CA 76(11): 59674v (1972).
CA 76(15): 85854y (1972).
CA 78(11): 66993t (1973).
CA 93(21): 197787m (1980).
CA 79(11): 66331w (1973).
CA 87(19): 145450c (1977).
CA 97(25): 208153n (1982).
CA 83(7): 58901z (1975).
CA 90(3): 23002z (1979).
CA 90(17): 137874r (1979).
CA 93(23): 215403q (1980).
CA 97(21): 174401z (1982).
CA 96(18): 149164w (1982).
Inoue et al., Chem. Pharm. Bull. 33 (3) 1256-1259 (1985).
CA 73(13): 66641y (1970).
Mohacsi Erno
O'Brien Jay P.
Boxer Matthew
Hoffmann-La Roche Inc.
Lee Mary C.
Leon Bernard S.
Saxe Jon S.
LandOfFree
Naphtho[1,2-b][1,4]thiazepin-4(5H)-ones and use thereof in treat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Naphtho[1,2-b][1,4]thiazepin-4(5H)-ones and use thereof in treat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphtho[1,2-b][1,4]thiazepin-4(5H)-ones and use thereof in treat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1367135